Tze‐Chiang Meng

2.6k total citations
31 papers, 1.7k citations indexed

About

Tze‐Chiang Meng is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Tze‐Chiang Meng has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 10 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in Tze‐Chiang Meng's work include Immunotherapy and Immune Responses (7 papers), Epilepsy research and treatment (5 papers) and Immune Response and Inflammation (5 papers). Tze‐Chiang Meng is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Epilepsy research and treatment (5 papers) and Immune Response and Inflammation (5 papers). Tze‐Chiang Meng collaborates with scholars based in United States, Canada and France. Tze‐Chiang Meng's co-authors include Richard L. Miller, Mark A. Tomai, Stephen K. Tyring, Frances D. Gillin, Michael L. Hetsko, Heather Patton, Paul J. Pockros, Myron J. Tong, Terry W. Wright and John G. McHutchison and has published in prestigious journals such as Blood, Annals of Internal Medicine and Neurology.

In The Last Decade

Tze‐Chiang Meng

30 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tze‐Chiang Meng United States 20 671 641 334 241 223 31 1.7k
C R Maliszewski United States 12 1.1k 1.6× 272 0.4× 191 0.6× 195 0.8× 310 1.4× 14 2.0k
S. Keay United States 23 230 0.3× 994 1.6× 148 0.4× 80 0.3× 224 1.0× 39 1.6k
Lars‐Åke Nilsson Sweden 17 950 1.4× 331 0.5× 247 0.7× 194 0.8× 438 2.0× 38 2.0k
Thomas M. McHugh United States 22 806 1.2× 482 0.8× 489 1.5× 178 0.7× 240 1.1× 36 2.1k
Jason D. Marshall United States 26 1.6k 2.4× 429 0.7× 168 0.5× 165 0.7× 368 1.7× 50 2.6k
Jennifer Ng United States 18 1.1k 1.6× 228 0.4× 197 0.6× 157 0.7× 630 2.8× 47 2.0k
Heidi Barth Germany 31 480 0.7× 1.4k 2.2× 275 0.8× 282 1.2× 559 2.5× 63 2.9k
Andrew Carmichael United Kingdom 18 1.1k 1.7× 877 1.4× 314 0.9× 191 0.8× 173 0.8× 48 2.0k
Alfred Μ. Legendre United States 25 180 0.3× 596 0.9× 558 1.7× 155 0.6× 196 0.9× 94 1.9k
Brian S. Sheridan United States 27 1.7k 2.5× 555 0.9× 254 0.8× 312 1.3× 382 1.7× 54 2.4k

Countries citing papers authored by Tze‐Chiang Meng

Since Specialization
Citations

This map shows the geographic impact of Tze‐Chiang Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tze‐Chiang Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tze‐Chiang Meng more than expected).

Fields of papers citing papers by Tze‐Chiang Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tze‐Chiang Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tze‐Chiang Meng. The network helps show where Tze‐Chiang Meng may publish in the future.

Co-authorship network of co-authors of Tze‐Chiang Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Tze‐Chiang Meng. A scholar is included among the top collaborators of Tze‐Chiang Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tze‐Chiang Meng. Tze‐Chiang Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Tze‐Chiang, et al.. (2025). Application of targeted next-generation sequencing for detecting respiratory pathogens in the sputum of patients with pulmonary infections. Infection Genetics and Evolution. 128. 105722–105722. 1 indexed citations
2.
Meng, Tze‐Chiang & Yuanhong Xu. (2025). Clinical Characteristics and Laboratory Diagnoses of Pediatric Patients Hospitalized During an Outbreak of Mycoplasma pneumoniae. Apmis. 133(1). e13514–e13514. 1 indexed citations
8.
Adams, Sylvia, Lina Kozhaya, Frank Martiniuk, et al.. (2012). Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer. Clinical Cancer Research. 18(24). 6748–6757. 184 indexed citations
9.
Quirk, Christopher J, Kurt Gebauer, Brian De’Ambrosis, Herbert B. Slade, & Tze‐Chiang Meng. (2010). Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study.. PubMed. 85(6). 318–24. 55 indexed citations
10.
Dummer, Reinhard, Axel Hauschild, Juergen C. Becker, et al.. (2008). An Exploratory Study of Systemic Administration of the Toll-like Receptor-7 Agonist 852A in Patients with Refractory Metastatic Melanoma. Clinical Cancer Research. 14(3). 856–864. 95 indexed citations
11.
Donaghy, Heather, Lidija Bosnjak, Andrew N. Harman, et al.. (2008). Role for Plasmacytoid Dendritic Cells in the Immune Control of Recurrent Human Herpes Simplex Virus Infection. Journal of Virology. 83(4). 1952–1961. 79 indexed citations
12.
Mark, Karen E., Lawrence Corey, Tze‐Chiang Meng, et al.. (2007). Topical Resiquimod 0.01% Gel Decreases Herpes Simplex Virus Type 2 Genital Shedding: A Randomized, Controlled Trial. The Journal of Infectious Diseases. 195(9). 1324–1331. 78 indexed citations
13.
Pockros, Paul J., Heather Patton, Myron J. Tong, et al.. (2007). Oral resiquimod in chronic HCV infection: Safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies. Journal of Hepatology. 47(2). 174–182. 171 indexed citations
14.
Spruance, Spotswood L., et al.. (2001). Application of a Topical Immune Response Modifier, Resiquimod Gel, to Modify the Recurrence Rate of Recurrent Genital Herpes: A Pilot Study. The Journal of Infectious Diseases. 184(2). 196–200. 73 indexed citations
15.
Que, Xuchu, Staffan G. Svärd, Tze‐Chiang Meng, et al.. (1996). Developmentally regulated transcripts and evidence of differential mRNA processing in Giardia lamblia. Molecular and Biochemical Parasitology. 81(1). 101–110. 39 indexed citations
16.
Meng, Tze‐Chiang, Stephen B. Aley, Staffan G. Svärd, et al.. (1996). Immunolocalization and sequence of caltractin/centrin from the early branching eukaryote Giardia lamblia. Molecular and Biochemical Parasitology. 79(1). 103–108. 37 indexed citations
17.
Meng, Tze‐Chiang, Michael L. Hetsko, & Frances D. Gillin. (1996). Inhibition of Giardia lamblia excystation by antibodies against cyst walls and by wheat germ agglutinin. Infection and Immunity. 64(6). 2151–2157. 32 indexed citations
18.
Kemper, Carol A., Tze‐Chiang Meng, Joseph Nussbaum, et al.. (1992). Treatment of Mycobacterium avium Complex Bacteremia in AIDS with a Four-Drug Oral Regimen. Annals of Internal Medicine. 116(6). 466–472. 110 indexed citations
19.
Nelson, Thomas R., et al.. (1992). Quantification of Amino Acids in Human Body Fluids by 1H Magnetic Resonance Spectroscopy A Specific Test for the Identification of Abscess. Investigative Radiology. 27(12). 999–1004. 8 indexed citations
20.
Meng, Tze‐Chiang, Margaret A. Fischl, Ahmad Boota, et al.. (1992). Combination Therapy with Zidovudine and Dideoxycytidine in Patients with Advanced Human Immunodeficiency Virus Infection. Annals of Internal Medicine. 116(1). 13–20. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026